Due to the low sensitivity and specificity of AFP in the screening and diagnosis of HCC, the European Association for the Study of The Liver and the American Association for the Study of Liver Diseases no longer suggest AFP as a screening and diagnosis standard in their updated guidelines for the diagnosis and treatment of liver cancer [25]. This evidence concerns the gene AFP and liver cancer.